SHAREHOLDERS' EQUITY (Details Textual)			1 Months Ended	3 Months Ended		12 Months Ended
	Jan. 07, 2025 $ / shares shares	Mar. 15, 2024 shares	Mar. 31, 2024 shares	Mar. 31, 2025 USD ($)	Mar. 31, 2024 shares	Dec. 31, 2015 $ / shares	Mar. 31, 2025 ₪ / shares	Mar. 31, 2025 USD ($) shares	Dec. 31, 2024 ₪ / shares shares	Dec. 28, 2016 USD ($)
Shareholders' Equity
Reverse share split, description			one-for-seven reverse share split of the Company’s ordinary shares		a reverse share split within a range of 1:2 to 1:12, to be effective at the ratio
Maximum number of authorized ordinary shares reverse share split					120,000,000
Issued and outstanding ordinary shares of reverse pre-split shares			60,100,000
Issued and outstanding ordinary shares of reverse post-split shares			8,600,000
Authorized number ordinary shares of reverse post-split shares		25,000,000
Number of share-based outstanding								4,551	4,573
Per share value of stock repurchase authorized | ₪ / shares							₪ 1.75		₪ 1.75
Treasury Stock, Common, Shares								574,658	574,658
Minimum [Member]
Shareholders' Equity
Authorized number ordinary shares of reverse post-split shares		30,000,000
Maximum [Member]
Shareholders' Equity
Authorized number ordinary shares of reverse post-split shares		43,750,000
Certain institutional purchasers [Member] | Registered direct offering of ordinary shares in July 2020 [Member]
Shareholders' Equity
Class of Warrant or Right, Number of Securities Called by Warrants or Rights								288,634
Proceeds from Warrant Exercises | $				$ 3,556,976
Certain institutional purchasers [Member] | Offering of ordinary shares in December 2020 [Member]
Shareholders' Equity
Class of Warrant or Right, Number of Securities Called by Warrants or Rights								514,010
Proceeds from Warrant Exercises | $				4,821,416
Placement agent [Member] | December 2020 private placement [Member]
Shareholders' Equity
Class of Warrant or Right, Number of Securities Called by Warrants or Rights								32,283
Proceeds from Warrant Exercises | $				$ 405,003
Purchase agreement for issuance and sale of ordinary shares and ordinary warrants
Shareholders' Equity
Exercise price per share | $ / shares	$ 2.75
Offering price per share | $ / shares	$ 2.75
Issuance of ordinary shares (in shares)	1,818,183
Class of Warrant or Right, Number of Securities Called by Warrants or Rights	1,818,183
Kreos Capital V [Member]
Shareholders' Equity
Exercise price per share | $ / shares						$ 52.5
Warrants grant date						Dec. 31, 2015
Warrants exercisable, description.				currently exercisable (in whole or in part) until the earlier of (i) December 30, 2025 or (ii) immediately prior to the consummation of a merger, consolidation, or reorganization of the Company with or into, or the sale or license of all or substantially all the assets or shares of the Company to, any other entity or person, other than a wholly owned subsidiary of the Company, excluding any transaction in which the Company’s shareholders prior to the transaction will hold more than 50% of the voting and economic rights of the surviving entity after the transaction. None of these warrants had been exercised as of March 31, 2025.
Drawdown amount under loan agreement | $										$ 8,000,000
H.C. Wainwright & Co. LLC | Purchase agreement for issuance and sale of ordinary shares and ordinary warrants
Shareholders' Equity
Exercise price per share | $ / shares	$ 3.4375
Class of Warrant or Right, Number of Securities Called by Warrants or Rights	109,091
Employee Stock Option [Member]
Shareholders' Equity
Award vesting period, description				Options to purchase ordinary shares generally vest over four years, with certain options to non-employee directors vesting quarterly over one year.
Unrecognized cost of shares | $								$ 1,200
Expected term of shares				1 year 10 months 24 days
Restricted Stock Units (RSUs) [Member] | Nonemployee [Member]
Shareholders' Equity
Number of share-based outstanding								0